Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 2:53 pm Sale | 2023-12-31 | 13G | INVIVO THERAPEUTICS HLDGS CORP NVIVQ | ARMISTICE CAPITAL LLC | 163,100 4.990% | -81,899 (-33.43%) | Filing History |
| 2024-02-13 8:09 pm Purchase | 2023-12-31 | 13G | INVIVO THERAPEUTICS HLDGS CORP NVIVQ | Lind Global Fund II LP | 125,520 3.900% | 125,520 (New Position) | Filing History |
| 2024-02-06 12:08 pm Sale | 2024-02-05 | 13G | INVIVO THERAPEUTICS HLDGS CORP NVIVQ | Foose Brice | 0 0.000% | -330,000 (Position Closed) | Filing History |
| 2023-04-25 5:37 pm Purchase | 2023-04-20 | 13G | INVIVO THERAPEUTICS HLDGS CORP NVIVQ | Foose Brice | 330,000 11.500% | 330,000 (New Position) | Filing History |
| 2023-02-14 1:13 pm Sale | 2022-12-31 | 13G | INVIVO THERAPEUTICS HLDGS CORP NVIVQ | ARMISTICE CAPITAL LLC | 244,999 9.990% | -9,598 (-3.77%) | Filing History |
| 2023-02-13 4:25 pm Sale | 2022-12-31 | 13G | INVIVO THERAPEUTICS HLDGS CORP NVIVQ | Lind Global Macro Fund LP | 128,321 6.300% | -3,009,679 (-95.91%) | Filing History |
| 2022-02-11 07:24 am Sale | 2021-12-31 | 13G | INVIVO THERAPEUTICS HLDGS CORP NVIVQ | Mitchell P. Kopin | 34,597 2.500% | -27,632 (-44.40%) | Filing History |
| 2022-02-09 5:02 pm Purchase | 2021-12-31 | 13G | INVIVO THERAPEUTICS HLDGS CORP NVIVQ | Lind Global Macro Fund LP | 125,520 8.400% | 34,759 (+38.30%) | Filing History |